stockportfolio.pro
TransMedics Group, Inc. P/E Ratio 2018–2025
TransMedics Group, Inc. (TMDX) annual price-to-earnings ratio by fiscal year, computed from SEC filings. Compound growth -12.1%/yr over 7 years.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 24.98 | -59.5% |
| FY 2024 | 61.73 | — |
| FY 2023 | — | — |
| FY 2022 | — | — |
| FY 2021 | — | — |
| FY 2020 | — | — |
| FY 2019 | — | — |
| FY 2018 | — | — |
Source: TransMedics Group, Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Refreshed nightly.
See the full picture for TransMedics Group, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeTransMedics Group, Inc. — frequently asked questions
What is TransMedics Group, Inc.'s price-to-earnings ratio?
TransMedics Group, Inc. (TMDX) reported price-to-earnings ratio of 24.98 for fiscal year 2025, per its SEC filings.
How has TransMedics Group, Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2018 and 2025, TMDX's price-to-earnings ratio declined at roughly 12.1% per year (compound annual rate), from 61.73 to 24.98.
Where does this data come from?
Figures are computed from TransMedics Group, Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.